Arrowhead Pharmaceuticals Inc (ARWR)
35.95
-0.65 -1.78%
NASDAQ
Oct 18, 20:00
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 136.76M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.46 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 45.51M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | 47.63% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00% |
| Price and Valuation | |
| Market Cap | 3.426B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 25.02 |
| PE Ratio (TTM) | 78.15 |
| Price to Book Value | 15.14 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.00 |
| Free Cash Flow (Quarterly) | 7.303M |
| Return on Equity (TTM) | Upgrade |
View All ARWR News
News
-
WireHeadlineTime (ET)
-
Yahoo10/18 16:38
-
Yahoo10/18 11:10
-
Business Wire10/18 07:30
-
SA Breaking News10/16 11:47
-
SA Breaking News10/10 17:51
-
Yahoo10/04 12:11
-
MT Newswires10/03 07:19
-
Business Wire10/02 16:15
-
Yahoo10/01 08:00
-
Business Wire09/30 16:00
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 12/11/2019 16:30 EST | Misc | Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2019 |
| 12/11/2019 | Earnings | Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release |
| 08/05/2019 16:30 EDT | Misc | Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2019 |
| 08/05/2019 | Earnings | Arrowhead Pharmaceuticals Inc Third Quarter Earnings in 2019 Release |
| 05/08/2019 16:30 EDT | Misc | Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2019 |
| 05/08/2019 | Earnings | Arrowhead Pharmaceuticals Inc Second Quarter Earnings in 2019 Release |
| 03/14/2019 10:00 PDT | Misc | Arrowhead Pharmaceuticals Inc Annual General Meeting in 2018 |
| 02/07/2019 16:30 EST | Misc | Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call in 2019 |
| 02/07/2019 | Earnings | Arrowhead Pharmaceuticals Inc First Quarter Earnings in 2019 Release |
| 12/11/2018 16:30 EST | Misc | Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2018 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.arrowheadpharma.com
- Investor Relations URL: http://ir.arrowheadpharma.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Growth
- Next Earnings Release: Dec. 11, 2019
- Last Earnings Release: Aug. 05, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 35.95 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| PSCH | Invesco S&P SmallCap Health Care ETF | 3.78% |
| PBE | Invesco Dynamic Biotech & Genome ETF | 2.92% |
| FMLYGX | FT Sabrient Small Cap Growth 23 RE | 2.84% |
| XBI | SPDR® S&P Biotech ETF | 1.93% |
| GOFFX | Invesco Oppenheimer Global Opp R5 | 1.87% |
| CPNFX | Invesco All Cap Market Neutral R5 | 1.73% |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 0.91% |
| SLYG | SPDR® S&P 600 Small Cap Growth ETF | 0.91% |
| QSSRX | AQR TM Small Cap Multi-Style R6 | 0.79% |
| PSAPX | Principal SmallCap S&P 600 Index R1 | 0.45% |
| IJR | iShares Core S&P Small-Cap ETF | 0.45% |
| CXXRX | Columbia Small Cap Index Inst2 | 0.45% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ARWR Tweets Stocktwits
Advertisement
